- Home
- ALHC
as of 12-30-2025 3:36pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 3.8B | IPO Year: | 2021 |
| Target Price: | $20.23 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.55 - $21.06 | Next Earning Date: | 10-30-2025 |
| Revenue: | $3,637,156,000 | Revenue Growth: | 47.39% |
| Revenue Growth (this year): | 48.66% | Revenue Growth (next year): | 31.23% |
AI-Powered ALHC Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
Chief Information Officer
Avg Cost/Share
$19.04
Shares
69,541
Total Value
$1,303,384.48
Owned After
506,827
Chief Executive Officer
Avg Cost/Share
$19.04
Shares
605,648
Total Value
$11,351,466.51
Owned After
2,267,505
President
Avg Cost/Share
$19.04
Shares
282,070
Total Value
$5,286,747.38
Owned After
1,400,634
Chief Legal and Admin. Officer
Avg Cost/Share
$19.04
Shares
16,187
Total Value
$303,388.01
Owned After
308,587
President
Avg Cost/Share
$20.01
Shares
113,319
Total Value
$2,267,150.57
Owned After
1,400,634
SEC Form 4
President
Avg Cost/Share
$20.02
Shares
16,681
Total Value
$333,960.29
Owned After
1,400,634
SEC Form 4
Director
Avg Cost/Share
$16.49
Shares
4,832
Total Value
$79,679.68
Owned After
1,081,141
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$16.32
Shares
180,000
Total Value
$2,936,772.00
Owned After
2,267,505
SEC Form 4
Director
Avg Cost/Share
$18.00
Shares
25,000
Total Value
$450,000.00
Owned After
1,081,141
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Scavo Robert L. | ALHC | Chief Information Officer | Dec 29, 2025 | Sell | $19.04 | 69,541 | $1,303,384.48 | 506,827 | |
| Kim Hyong | ALHC | Chief Medical Officer | Dec 29, 2025 | Sell | $19.04 | 12,694 | $237,919.52 | 349,639 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Dec 29, 2025 | Sell | $19.04 | 605,648 | $11,351,466.51 | 2,267,505 | |
| Maroney Dawn Christine | ALHC | President | Dec 29, 2025 | Sell | $19.04 | 282,070 | $5,286,747.38 | 1,400,634 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Dec 29, 2025 | Sell | $19.04 | 16,187 | $303,388.01 | 308,587 | |
| Maroney Dawn Christine | ALHC | President | Dec 15, 2025 | Sell | $20.01 | 113,319 | $2,267,150.57 | 1,400,634 | |
| Maroney Dawn Christine | ALHC | President | Dec 12, 2025 | Sell | $20.02 | 16,681 | $333,960.29 | 1,400,634 | |
| KONOWIECKI JOSEPH S | ALHC | Director | Nov 11, 2025 | Sell | $16.49 | 4,832 | $79,679.68 | 1,081,141 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Nov 10, 2025 | Sell | $16.32 | 180,000 | $2,936,772.00 | 2,267,505 | |
| KONOWIECKI JOSEPH S | ALHC | Director | Oct 28, 2025 | Sell | $18.00 | 25,000 | $450,000.00 | 1,081,141 |
Compare ALHC vs Leading Stocks
See how ALHC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.